http://www.unboundmedicine.com/medline/ebm/research/Vytorin_10_40Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19764858/full_citation/The_Vytorin_on_Carotid_Media_Thickness_and_Overall_Arterial_Rigidity__VYCTOR__study_Farmer J 
The Vytorin on Carotid-Media Thickness and Overall Arterial Rigidity (VYCTOR) study. [Journal Article]
Expert Rev Cardiovasc Ther 2009 Sep; 7(9):1057-60.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19443679/full_citation/The_VYtorin_on_Carotid_intima_media_thickness_and_overall_arterial_rigidity__VYCTOR__study_Meaney A, Ceballos G, Asbun J, et al. 
The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study. [Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Clin Pharmacol 2009 Jul; 49(7):838-47.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19061694/full_citation/Rationale_and_design_of_IMPROVE_IT__IMProved_Reduction_of_Outcomes:_Vytorin_Efficacy_International_Trial_:_comparison_of_ezetimbe/simvastatin_versus_simvastatin_monotherapy_on_cardiovascular_outcomes_in_patients_with_acute_coronary_syndromes_Cannon CP, Giugliano RP, Blazing MA, et al. 
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. [Journal Article]
Am Heart J 2008 Nov; 156(5):826-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19018143/full_citation/Efficacy_of_Ezetimibe/Simvastatin_10/40_mg_Compared_to_Doubling_the_Dose_of_Low__Medium__and_High_Potency_Statin_Monotherapy_in_Patients_with_a_Recent_Coronary_Event_Brudi P, Reckless JP, Henry DP, et al. 
Efficacy of Ezetimibe/Simvastatin 10/40 mg Compared to Doubling the Dose of Low-, Medium- and High-Potency Statin Monotherapy in Patients with a Recent Coronary Event. [JOURNAL ARTICLE]
Cardiology 2008 Nov 15; 113(2):89-97.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17966796/full_citation/[Drug_of_the_month__Ezetimibe/simvastatin_tablet__Inegy_]Scheen AJ, Radermecker RP 
[Drug of the month. Ezetimibe/simvastatin tablet (Inegy)] [English Abstract, Journal Article]
Rev Med Liege 2007 Sep; 62(9):585-90.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17655686/full_citation/A_multi_centre_randomised_double_blind_14_week_extension_study_examining_the_long_term_safety_and_efficacy_profile_of_the_ezetimibe/simvastatin_combination_tablet_Ose L, Johnson-Levonas A, Reyes R, et al. 
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet. [Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Int J Clin Pract 2007 Sep; 61(9):1469-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17560879/full_citation/Comparison_of_effects_of_ezetimibe/simvastatin_versus_simvastatin_versus_atorvastatin_in_reducing_C_reactive_protein_and_low_density_lipoprotein_cholesterol_levels_Pearson T, Ballantyne C, Sisk C, et al. 
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. [Comparative Study, Journal Article, Meta-Analysis]
Am J Cardiol 2007 Jun 15; 99(12):1706-1713.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17407627/full_citation/Dual_cholesterol_inhibition_with_ezetimibe/simvastatin_in_pre_treated_hypercholesterolaemic_patients_with_coronary_heart_disease_or_diabetes_mellitus:_prospective_observational_cohort_studies_in_clinical_practice_Hildemann SK, Barho C, Karmann B, et al. 
Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice. [Comparative Study, Evaluation Studies, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Curr Med Res Opin 2007 Apr; 23(4):713-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17200833/full_citation/The_effect_of_simvastatin_ezetimibe_and_their_combination_on_the_lipid_profile_arterial_stiffness_and_inflammatory_markers_Efrati S, Averbukh M, Dishy V, et al. 
The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers. [JOURNAL ARTICLE]
Eur J Clin Pharmacol 2007 Jan 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17022864/full_citation/Lipid_altering_efficacy_of_the_ezetimibe/simvastatin_single_tablet_versus_rosuvastatin_in_hypercholesterolemic_patients_Catapano AL, Davidson MH, Ballantyne CM, et al. 
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. [Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Curr Med Res Opin 2006 Oct; 22(10):2041-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles